logo
  

Natural Resource Partners CFO Dwight Dunlap To Retire - Quick Facts

Natural Resource Partners L.P. (NRP) announced that Dwight Dunlap, NRP's Chief Financial Officer and Treasurer, will retire from the company on December 31, 2014.

Following his retirement from NRP, Dunlap will remain with Quintana Minerals Corporation and other Robertson family businesses and will continue to provide services to NRP to ensure a seamless transition.

The company noted that Craig Nunez will succeed Dunlap as Chief Financial Officer and Treasurer of NRP.

Craig Nunez joins NRP with 27 years of global experience in finance, spanning the upstream, midstream and downstream sectors of the oil and gas industry. Most notable of Nunez's previous roles were senior vice president and treasurer of Halliburton, one of the world's largest oil service companies; treasurer of Colonial Pipeline, owner of the world's largest petroleum products pipeline; and director of International New Ventures at Phillips Petroleum. Most recently, he served as chief executive officer of Bocage Group, a private investment company specializing in energy, natural resources and master limited partnerships.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT